希玛眼科发布公告,公司英文名称已由“C-MER EYE CARE HOLDINGS LIMITED”更改为“C-MER Medical Holdings Limited”,而公司的中文双重外文名称已由“希玛眼科医疗控股有限公司”更改为“希玛医疗控股有限公司”。于香港联合交易所有限公司买卖股份的英文股份简称将由“C-MER EYE”更改为“C-MER MEDICAL”,而中文股份简称则由“希玛眼科”更改为“希玛医疗”,自2024年6月27日上午9时正起生效。公司的股份代号“03309”维持不变。
English
Back
- Markets
- Features
- News
- Community
- Learn
- Help Center
- About
- Offers & Rewards
- Welcome RewardsOpen an account and get up to HKD1600!
- Enjoy limited-time 5%+5% returns on Cash PlusInvest any amount and enjoy a 5% average return on Cash Plus + 5% welcome reward
- Learn PremiumAnalyst 1V1 online teaching
- Referral PromotionBring a friend and collect up to HK$600 in rewards
- Stock TransferSwitch to Futu and get up to HK$7,000 in rewards
- English
- 繁體中文
- 简体中文
- Dark
- Light
希玛眼科更名为“希玛医疗控股有限公司”
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.